CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended
	Oct. 31, 2025	Oct. 31, 2024
EXPENSES
Accretion expense	$ 8,018	$ 29,859
Consulting	50,028	55,106
Directors' fees	20,000	30,000
Filing and regulatory	25,716	23,997
Foreign exchange (gain) loss	2,794	2,127
General and administrative	113,595	74,365
Geological, mineral, and prospect costs	64,644	45,162
Interest expense	3,915	96,201
Professional fees	513,775	100,881
Promotion and shareholder communication	24,000	8,187
Share-based compensation	564,240	162,508
Loss	(1,390,725)	(628,393)
Interest income	41,357	0
Net loss and comprehensive loss for the period	$ (1,349,368)	$ (628,393)
Basic loss per common share	$ (0.01)	$ (0.01)
Diluted loss per common share	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding, basic	94,524,313	55,785,106
Weighted average number of common shares outstanding, diluted	94,524,313	55,785,106